Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.
Choi IJ, Kook M-C, Kim Y-I, Cho S-J, Lee JY, Kim CG, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–95.
Article CAS PubMed Google Scholar
Nakata R, Nagami Y, Hashimoto A, Sakai T, Ominami M, Fukunaga S, et al. Successful eradication of Helicobacter pylori could prevent metachronous gastric cancer: a propensity matching analysis. Digestion. 2021;102:236–45.
Watari J, Tomita T, Tozawa K, Oshima T, Fukui H, Miwa H. Preventing metachronous gastric cancer after the endoscopic resection of gastric epithelial neoplasia: roles of Helicobacter pylori eradication and aspirin. Gut Liver. 2020;14:281–90.
Article CAS PubMed Google Scholar
Kwak HW, Choi IJ, Cho SJ, Lee JY, Kim CG, Kook MC, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol. 2014;29:1671–7.
Na JH, Lee SY, Kim JH, Sung IK, Park HS. Helicobacter pylori infection status and gastric tumor incidence according to the year of birth. Gut Liver. 2024;18:457–64.
Yamada A, Kaise M, Inoshita N, Toba T, Nomura K, Kuribayashi Y, et al. Characterization of Helicobacter pylori-naïve early gastric cancers. Digestion. 2018;98:127–34.
Article CAS PubMed Google Scholar
Ishibashi F, Suzuki S, Nagai M, Mochida K, Morishita T. Optimizing Helicobacter pylori treatment: an updated review of empirical and susceptibility test-based treatments. Gut Liver. 2023;17:684–97.
Article CAS PubMed PubMed Central Google Scholar
Kotani S, Shibagaki K, Hirahara N, Hasegawa N, Tanabe R, Ebisutani Y, et al. Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis. J Gastroenterol. 2024;59:1–10.
Ishibashi F, Hirasawa T, Ueyama H, Minato Y, Suzuki S. Exploring quality indicators for the detection of Helicobacter pylori-naïve gastric cancer: a cross-sectional nationwide survey. Clin Endosc. 2023;56:460–9.
Article PubMed PubMed Central Google Scholar
Ishibashi F, Kobayashi K, Kawakami T, Tanaka R, Sugihara K, Baba S. Quality management system for screening esophagogastroduodenoscopy improves detection of Helicobacter pylori -negative interval gastric cancer. Endosc Int Open. 2021;9:E1900–8.
Article PubMed PubMed Central Google Scholar
Ishibashi F, Kobayashi K, Fukushima K, Tanaka R, Kawakami T, Kato J, et al. Quality indicators for the detection of Helicobacter pylori-negative early gastric cancer: a retrospective observational study. Clin Endosc. 2020;53:698–704.
Article PubMed PubMed Central Google Scholar
Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609–19.
Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 2014;46:153–7.
Ueyama H, Yao T, Akazawa Y, Hayashi T, Kurahara K, Oshiro Y, et al. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol. 2021;56:814–28.
Article CAS PubMed PubMed Central Google Scholar
Ishibashi F, Fukushima K, Ito T, Kobayashi K, Tanaka R, Onizuka R. Influence of Helicobacter pylori infection on endoscopic findings of gastric adenocarcinoma of the fundic gland type. J Gastric Cancer. 2019;19:225–33.
Article PubMed PubMed Central Google Scholar
Shibagaki K, Fukuyama C, Mikami H, Izumi D, Yamashita N, Mishiro T, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori -uninfected stomach. Endosc Int Open. 2019;7:E784–91.
Article PubMed PubMed Central Google Scholar
Shibagaki K, Ishimura N, Kotani S, Fukuyama C, Takahashi Y, Kishimoto K, et al. Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylori-naïve patients. Gastric Cancer. 2023;26:1002–11.
Article CAS PubMed Google Scholar
Horiuchi Y, Hirasawa T, Fujisaki J. Endoscopic features of undifferentiated-type early gastric cancer in patients with Helicobacter pylori-uninfected or -eradicated stomachs: a comprehensive review. Gut Liver. 2024;18:209–17.
Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, et al. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer. 2021;24:1102–14.
Article CAS PubMed Google Scholar
Cho SY, Park JW, Liu Y, Park YS, Kim JH, Yang H, et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology. 2017;153:536-549.e26.
Article CAS PubMed Google Scholar
Kiso M, Urabe Y, Ito M, Masuda K, Boda T, Kotachi T, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol. 2020;20:243.
Article CAS PubMed PubMed Central Google Scholar
Funakoshi T, Miyamoto S, Kakiuchi N, Nikaido M, Setoyama T, Yokoyama A, et al. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer. Gastric Cancer. 2019;22:892–8.
Horiuchi Y, Fujisaki J, Ishizuka N, Omae M, Ishiyama A, Yoshio T, et al. Study on clinical factors involved in Helicobacter pylori-uninfected, undifferentiated-type early gastric cancer. Digestion. 2017;96:213–9.
Article CAS PubMed Google Scholar
Gastric J. Cancer association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.
Ishibashi F, Suzuki S, Kobayashi K, Tanaka R, Kawakami T, Mochida K, Nagai M, Ishibashi Y, Morishita T. Cost-effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment. J Gastroenterol Hepatol. 2024. https://doi.org/10.1111/jgh.16509.
Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS ONE. 2013;8:e79088.
Article PubMed PubMed Central Google Scholar
Hamashima C, Shabana M, Okada K, Okamoto M, Osaki Y. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci. 2015;106:1744–9.
Article CAS PubMed PubMed Central Google Scholar
Jun JK, Choi KS, Lee H-Y, Suh M, Park B, Song SH, et al. Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319-28.e7.
Noh C-K, Lee E, Lee GH, Kang JK, Lim SG, Park B, et al. Association of intensive endoscopic screening burden with gastric cancer detection. JAMA Netw Open. 2021;4:e2032542.
Article PubMed PubMed Central Google Scholar
Kusano C, Gotoda T, Ishikawa H, Suzuki S, Ikehara H, Matsuyama Y. Gastric cancer detection rates using gastrointestinal endoscopy with serological risk stratification: a randomized controlled trial. Gastrointest Endosc. 2024. https://doi.org/10.1016/j.gie.2024.01.022.
留言 (0)